Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Evidence for circulating bone marrow-derived endothelial cells

Q Shi1, S Rafii, M H Wu

  • 1Department of Surgery, The Hope Heart Institute and Providence Medical Center, Seattle, WA 98122, USA.

Blood
|July 10, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cooling positronium to ultralow velocities with a chirped laser pulse train.

Nature·2024
Same author

Thermal and impact histories of 25143 Itokawa recorded in Hayabusa particles.

Scientific reports·2018
Same author

Erratum: Observation of the hyperfine spectrum of antihydrogen.

Nature·2017
Same author

Antihydrogen accumulation for fundamental symmetry tests.

Nature communications·2017
Same author

Observation of the hyperfine spectrum of antihydrogen.

Nature·2017
Same author

Observation of the 1S-2S transition in trapped antihydrogen.

Nature·2016

Bone marrow stem cells (CD34+ cells) can transform into endothelial cells, forming new blood vessels. This discovery suggests a potential for regenerating blood vessels using these unique bone marrow cells.

Area of Science:

  • Hematology
  • Cell Biology
  • Vascular Biology

Background:

  • The hemangioblast is a proposed common precursor for hematopoietic and endothelial cells.
  • Understanding endothelial cell precursors is crucial for regenerative medicine and vascular biology.

Purpose of the Study:

  • To investigate the potential of CD34+ cells to differentiate into endothelial cells.
  • To confirm the in vivo existence and function of bone marrow-derived endothelial precursor cells.

Main Methods:

  • In vitro differentiation of CD34+ cells using growth factors (bFGF, IGF-1, VEGF).
  • Characterization of differentiated cells using CD34 marker, von Willebrand factor (vWF) staining, and acetylated low-density lipoprotein (LDL) uptake.
  • Canine bone marrow transplantation model with genetically distinct donor and recipient cells.

Related Experiment Videos

  • Implantation of an impervious Dacron graft in the aorta, followed by retrieval and analysis of cells using silver nitrate staining and DNA polymorphism analysis.

    • Main Results:

    • A subset of CD34+ cells differentiated into endothelial cells in vitro, expressing vWF and incorporating LDL.
    • In vivo studies demonstrated that cells with endothelial morphology on the Dacron graft were of donor origin.
    • These findings indicate that bone marrow-derived CD34+ cells can mobilize and colonize vascular prostheses.

    Conclusions:

    • Bone marrow contains a population of CD34+ cells capable of differentiating into endothelial cells.
    • These precursor cells can be mobilized into circulation and contribute to endothelialization of vascular grafts.
    • This research supports the existence of bone marrow-derived endothelial precursor cells with therapeutic potential.